CAACB Team

Paul Barone, PhD
Associate Director, CAACB
Associate Director, BioMAN Research Program, MIT CBI
pbarone@mit.edu

James Leung, PhD
Lead Investigator, CAACB
Visiting Scientist, MIT
leungjc@mit.edu

Stacy Springs, PhD
Executive Director, CAACB
Executive Director BioMAN Research Program, MIT CBI
ssprings@mit.edu

Michael E. Wiebe, PhD
Lead Investigator, CAACB
President and Founder, Quantum Consulting
quantumco@comcast.net

Anthony Sinskey, ScD
Faculty Director, CBI
Professor of Biology and Health Sciences and Technology, MIT

Alnylam Pharmaceuticals (www.alnylam.com)

Amgen (www.amgen.com)

Baxter (www.baxter.com)

Biogen Idec (www.biogenidec.com)

BioMarin (www.bmrn.com)

Boehringer Ingelheim (http://www.boehringer-ingelheim.com)

Bristol-Myers Squibb (http://www.bms.com/pages/default.aspx)

EMD Millipore (www.emdmillipore.com)

Genentech (www.gene.com)

Genzyme (www.genzyme.com)

MedImmune (www.medimmune.com)

Merial (www.merial.com)

Merrimack Pharmaceuticals (www.merrimackpharma.com)

Novartis Pharma AG (www.novartis.com)

Pfizer (www.pfizer.com)

Sanofi (www.sanofi.com)

sanofi pasteur (www.sanofipasteur.com)

Kurt Brorson, PhD
Staff Scientist, Division of Monoclonal Antibodies, CDER/FDA

Marshall Dinowitz, ScD
Partner and Sr. Consultant, Pacific BioDevelopment LLC

Jim Gombold, PhD
Director, Testing Services, Charles River Laboratories

Bill Lucas, PhD
Director of Assay Development, WuXi AppTec Inc.

Carol Marcus-Sekura, PhD
Executive Vice President, BASI

Raymond Nims, PhD
Sr. Consultant, RMC Pharma

Anton F. Steuer, PhD
Principal Scientist, Program Management and Development, BioReliance

Hannelore Willkommen, PhD
Directorate, RBS Consulting

Ruth Wolff, PhD
Director of Therapeutics, Biologics Consulting Group